Standard
Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity. / Mathiesen, Caroline B.K.; Carlsson, Michael C.; Brand, Stephanie; Möller, Svenning Rune; Idorn, Manja; Straten, Per thor ; Pedersen, Anders E.; Dabelsteen, Sally; Halim, Adnan; Würtzen, Peter Adler; Brimnes, Jens; Ipsen, Henrik; Petersen, Bent L; Wandall, Hans H.
In:
Journal of Allergy and Clinical Immunology, Vol. 142, No. 6, 2018, p. 1983-1987.
Research output: Contribution to journal › Letter › Research › peer-review
Harvard
Mathiesen, CBK, Carlsson, MC, Brand, S, Möller, SR, Idorn, M, Straten, PT
, Pedersen, AE, Dabelsteen, S, Halim, A, Würtzen, PA, Brimnes, J, Ipsen, H
, Petersen, BL & Wandall, HH 2018, '
Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity',
Journal of Allergy and Clinical Immunology, vol. 142, no. 6, pp. 1983-1987.
https://doi.org/10.1016/j.jaci.2018.07.030APA
Mathiesen, C. B. K., Carlsson, M. C., Brand, S., Möller, S. R., Idorn, M., Straten, P. T.
, Pedersen, A. E., Dabelsteen, S., Halim, A., Würtzen, P. A., Brimnes, J., Ipsen, H.
, Petersen, B. L., & Wandall, H. H. (2018).
Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity.
Journal of Allergy and Clinical Immunology,
142(6), 1983-1987.
https://doi.org/10.1016/j.jaci.2018.07.030Vancouver
Mathiesen CBK, Carlsson MC, Brand S, Möller SR, Idorn M, Straten PT et al.
Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity.
Journal of Allergy and Clinical Immunology. 2018;142(6):1983-1987.
https://doi.org/10.1016/j.jaci.2018.07.030Author
Mathiesen, Caroline B.K. ; Carlsson, Michael C. ; Brand, Stephanie ; Möller, Svenning Rune ; Idorn, Manja ; Straten, Per thor ; Pedersen, Anders E. ; Dabelsteen, Sally ; Halim, Adnan ; Würtzen, Peter Adler ; Brimnes, Jens ; Ipsen, Henrik ; Petersen, Bent L ; Wandall, Hans H. / Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity. In: Journal of Allergy and Clinical Immunology. 2018 ; Vol. 142, No. 6. pp. 1983-1987.
Bibtex
@article{32d91ef5c5744ea1afdda4c9a9a746ad,
title = "Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity",
author = "Mathiesen, {Caroline B.K.} and Carlsson, {Michael C.} and Stephanie Brand and M{\"o}ller, {Svenning Rune} and Manja Idorn and Straten, {Per thor} and Pedersen, {Anders E.} and Sally Dabelsteen and Adnan Halim and W{\"u}rtzen, {Peter Adler} and Jens Brimnes and Henrik Ipsen and Petersen, {Bent L} and Wandall, {Hans H.}",
year = "2018",
doi = "10.1016/j.jaci.2018.07.030",
language = "English",
volume = "142",
pages = "1983--1987",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "6",
}
RIS
TY - JOUR
T1 - Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity
AU - Mathiesen, Caroline B.K.
AU - Carlsson, Michael C.
AU - Brand, Stephanie
AU - Möller, Svenning Rune
AU - Idorn, Manja
AU - Straten, Per thor
AU - Pedersen, Anders E.
AU - Dabelsteen, Sally
AU - Halim, Adnan
AU - Würtzen, Peter Adler
AU - Brimnes, Jens
AU - Ipsen, Henrik
AU - Petersen, Bent L
AU - Wandall, Hans H.
PY - 2018
Y1 - 2018
U2 - 10.1016/j.jaci.2018.07.030
DO - 10.1016/j.jaci.2018.07.030
M3 - Letter
C2 - 30125661
VL - 142
SP - 1983
EP - 1987
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
SN - 0091-6749
IS - 6
ER -
